Core - Biomarker Reference Laboratory (BRL)
Core - Biomarker Reference Laboratory (BRL)
批准号:
10705806
负责人:
JAMES G. HERMAN
金额:
$19.77万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-16 至 2027-08-31
关键词:
AddressBaltimoreBenignBiological AssayBiological MarkersBiopsyBlindedBody FluidsCLIA certifiedCancer EtiologyCategoriesCellsCessation of lifeCharacteristicsClinicalCollaborationsDNA MethylationDetectionDevelopmentDiagnostic ProcedureDiameterDiseaseEarly Detection Research NetworkEarly DiagnosisEnsureEvaluationExhibitsFundingHealthcareImageKnowledgeLaboratoriesLesionLongterm Follow-upLungMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of lungMarylandMethodologyMethodsMethylationMorbidity - disease rateNoduleOperative Surgical ProceduresParticipantPatientsPerformancePlasmaPopulationPredictive ValueProceduresQuality ControlReagentReproducibilityResearch PersonnelSamplingScreening ResultSpecificityStandardizationTechnologyTestingTimeUniversitiesValidationarmassay developmentbiomarker developmentbiomarker validationcandidate markerexperienceflexibilitylaboratory developmentliquid biopsylung cancer screeningmethylation biomarkermortalitymultidisciplinaryprospectivesample collectionscreeningwasting
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Biomarker Reference Laboratory (BRL) will be led by Dr. Sanford Stass and as a
component of the BCC will develop, refine, and standardize the biomarkers assays developed
by the Biomarker Development Laboratory. This BRL is a continuation of the University of
Maryland Baltimore Biomarker Reference Laboratory. UMB-BRL has for the past 15 years
provided active support of the EDRN, including testing of candidate biomarkers, development of
assays and technologies, and standardization of assay methods in collaboration with multiple
investigators in the EDRN. The proposed BRL includes a multi-disciplinary team of directors/co-
investigators and staff with broad knowledge, experience and expertise in application of
technology for biomarkers including reagent and assay development and implementation,
validation of laboratory methodology and assays, quality control for reagents and technologies,
evaluation of accuracy, precision, reproducibility and characteristics of performance including
sensitivity, specificity, and positive and negative predictive values. The BRL will bring DNA
methylation biomarkers from the BDL into a CLIA compliant laboratory using developed
standard operating procedures (SOPs), and extensive experience in collaborative studies in
biomarker validation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10705801
-
项目类别:
-
资助金额:$29.96万
-
财政年份:2022
-
负责人:JAMES G. HERMAN
-
依托单位:
Optimizing Ultrasensitive DNA methylation detection for lung cancer and other malignancies
-
批准号:10705752
-
项目类别:
-
资助金额:$87.97万
-
财政年份:2022
-
负责人:JAMES G. HERMAN
-
依托单位:
Core - Biomarker Development Laboratory (BDL)
-
批准号:10705802
-
项目类别:
-
资助金额:$38.24万
-
财政年份:2022
-
负责人:JAMES G. HERMAN
-
依托单位:
Ultrasensitive Detection of Tumor Specific DNA Methylation Changes for the Early Detection of Lung Cancer
-
批准号:9277030
-
项目类别:
-
资助金额:$59.46万
-
财政年份:2016
-
负责人:JAMES G. HERMAN
-
依托单位:
Ultrasensitive Detection of Tumor Specific DNA Methylation Changes for the Early Detection of Lung Cancer
-
批准号:10463037
-
项目类别:
-
资助金额:$23.37万
-
财政年份:2016
-
负责人:JAMES G. HERMAN
-
依托单位:
Ultrasensitive Detection of Tumor Specific DNA Methylation Changes for the Early Detection of Lung Cancer
-
批准号:9353351
-
项目类别:
-
资助金额:$58.14万
-
财政年份:2016
-
负责人:JAMES G. HERMAN
-
依托单位:
CHFR Methylation for Predicting Taxane Sensitivity in Lung and Esophageal Cancer
-
批准号:7667386
-
项目类别:
-
资助金额:$27.06万
-
财政年份:2008
-
负责人:JAMES G. HERMAN
-
依托单位:
P1: Epigenetic Staging and Therapy for Lung Cancers
-
批准号:7567913
-
项目类别:
-
资助金额:$42.65万
-
财政年份:2008
-
负责人:JAMES G. HERMAN
-
依托单位:
CHFR Methylation for Predicting Taxane Sensitivity in Lung and Esophageal Cancer
-
批准号:7892354
-
项目类别:
-
资助金额:$27.06万
-
财政年份:2008
-
负责人:JAMES G. HERMAN
-
依托单位:
CHFR Methylation for Predicting Taxane Sensitivity in Lung and Esophageal Cancer
-
批准号:8116517
-
项目类别:
-
资助金额:$26.25万
-
财政年份:2008
-
负责人:JAMES G. HERMAN
-
依托单位:
CHFR Methylation for Predicting Taxane Sensitivity in Lung and Esophageal Cancer
-
批准号:7665203
-
项目类别:
-
资助金额:$27.06万
-
财政年份:2008
-
负责人:JAMES G. HERMAN
-
依托单位:
CHFR Methylation for Predicting Taxane Sensitivity in Lung and Esophageal Cancer
-
批准号:7239131
-
项目类别:
-
资助金额:$22.96万
-
财政年份:2007
-
负责人:JAMES G. HERMAN
-
依托单位:
SPORE in Lung Cancer
-
批准号:8729242
-
项目类别:
-
资助金额:$216.2万
-
财政年份:2001
-
负责人:JAMES G. HERMAN
-
依托单位:
Cancer Epidemiology and Prevention Program
-
批准号:10254110
-
项目类别:
-
资助金额:$3.56万
-
财政年份:1997
-
负责人:JAMES G. HERMAN
-
依托单位:
Cancer Epidemiology and Prevention Program
-
批准号:10474529
-
项目类别:
-
资助金额:$4.01万
-
财政年份:1997
-
负责人:JAMES G. HERMAN
-
依托单位:
Cancer Epidemiology and Prevention Program
-
批准号:10674857
-
项目类别:
-
资助金额:$4.01万
-
财政年份:1997
-
负责人:JAMES G. HERMAN
-
依托单位:
Cancer Epidemiology and Prevention Program
-
批准号:10024350
-
项目类别:
-
资助金额:$3.95万
-
财政年份:1997
-
负责人:JAMES G. HERMAN
-
依托单位:
P1: Epigenetic Staging and Therapy for Lung Cancers
-
批准号:8022844
-
项目类别:
-
资助金额:$27.99万
-
财政年份:--
-
负责人:JAMES G. HERMAN
-
依托单位:
Lung Cancer Program (Project-009)
-
批准号:9753991
-
项目类别:
-
资助金额:$3.45万
-
财政年份:--
-
负责人:JAMES G. HERMAN
-
依托单位:
P1: Epigenetic Staging and Therapy for Lung Cancers
-
批准号:8374581
-
项目类别:
-
资助金额:$34.2万
-
财政年份:--
-
负责人:JAMES G. HERMAN
-
依托单位:
海外基金